2005
DOI: 10.1111/j.1365-2893.2005.00684.x
|View full text |Cite
|
Sign up to set email alerts
|

Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes

Abstract: Hepatitis C virus (HCV) infection represents an important global health problem. Current antiviral therapeutics for HCV have proven inadequate in stemming the disease process. A novel therapeutic strategy involves the use of deoxyribozymes, also known as DNA enzymes or DNAzymes. These catalytic DNA molecules, designed to target and cleave specific RNA sequences, have shown promise in in vitro experimental models for various diseases and may serve as an alternative or adjunct to current HCV drug therapy. We des… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(15 citation statements)
references
References 45 publications
0
15
0
Order By: Relevance
“…The Dz Dz858-15-15 [72] decreased the level of viral RNA by 30 --50% depending on cell type. Both mRNA and protein expression from the cloned core gene were reduced substantially when the gene was co-transfected with anti-core Dz CDz [19].…”
Section: Hepatitis B and C Virusesmentioning
confidence: 97%
See 2 more Smart Citations
“…The Dz Dz858-15-15 [72] decreased the level of viral RNA by 30 --50% depending on cell type. Both mRNA and protein expression from the cloned core gene were reduced substantially when the gene was co-transfected with anti-core Dz CDz [19].…”
Section: Hepatitis B and C Virusesmentioning
confidence: 97%
“…Other Dzs also were constructed to bind conserved sequences of the core protein regions of the viral RNA [19,72]. The Dz Dz858-15-15 [72] decreased the level of viral RNA by 30 --50% depending on cell type.…”
Section: Hepatitis B and C Virusesmentioning
confidence: 99%
See 1 more Smart Citation
“…Target RNA for in vivo deoxyribozyme-catalyzed cleavage References Egr1 zinc finger transcription factor [139 -142] Epstein-Barr virus latent membrane protein [143] Hepatitis B virus X protein [144] Hepatitis B virus HBs and HBe antigens [145] Hepatitis C virus core protein [146] HIV-1 Gag [147 -149] HIV-1 Tat protein [150,151] HIV-1 5'-untranslated region [152] Human telomerase reverse transcriptase [153] Influenza virus A [154] Isocitrate lyase from M. tuberculosis [155] c-Jun leucine zipper transcription factor [156,157] b-Lactamase [158,159] 12-Lipoxygenase [160] c-Myc proto-oncogene [161 -163] Ornithine decarboxylase [164] Pencillin-binding protein [165] PML/RARa fusion gene of acute promyelocytic leukemia [166] Respiratory syncytial virus (RSV) nucleocapsid protein [167] SARS associated coronavirus 5'-untranslated region [168] Survivin [169] TGF-b1 [170] Twist helix-loop-helix transcription factor [171] Vascular endothelial growth factor receptor 2 (VEGFR) [172] This tabulation is representative, not comprehensive. Additional examples and reviews are cited in ref.…”
Section: Rna-cleaving Deoxyribozymes As In Vivo Therapeutic Agentsmentioning
confidence: 99%
“…For the particular case of HCV, as far as we know, only one report dealing with a DNAzyme carrying four 2'-O-methylnucleotides consecutively located on the distal ends of the annealing arms is known. [20] On the other hand, due to the sensitive structure-activity relationship the catalytic core presents, there are only a few examples of chemical modifications in the 10-23 DNAzyme catalytic core, using for example 2'-O-methylnucleosides, [18] phosphorothioates, [21] amino-acid-like bases, [22] or abasic phosphoramidites. [23] In this sense, the 2'-C-methyl-2'-deoxynucleosides [24] constitutes an interesting nucleoside class, because they show differential preferred sugar conformations depending on the absolute configuration at the 2'-carbon.…”
Section: Introductionmentioning
confidence: 99%